Aberrant Right Subclavian Artery with Kommerell’s Diverticulum and Patent Ductus Arteriosus: Unusual Combination of Congenital Heart Anomalies and Clinical Manifestations in A Neonate
DOI:
https://doi.org/10.1532/hsf.4455Keywords:
aberrant right subclavian artery, Kommerell’s diverticulum, patent ductus arteriosus, necrotizing enterocolitisAbstract
Background: A one-month-old neonate presented to the hospital with dyspnea and bloody stool, which happened suddenly and progressed over two days.
Case presentation: Computed tomography and three-dimensional reconstruction of the trachea and heart was done, demonstrating significant trachea stenosis, aberrant right subclavian artery arising from Kommerell’s diverticulum, and patent ductus arteriosus. Reconstruction of the aberrant subclavian artery, resection of the diverticulum, and ligation of ductus arteriosus was performed.
Conclusion: The case reported a rare combination of congenital anomalies and rare clinical manifestations at the same time. We thought the anatomical anomalies caused necrotizing enterocolitis (NEC), which lead to bloody stool.
References
Azeem SM, Arif U, Baig R, Khan MI. 2021. "Case report: A rare cause of chest pain: Kommerell's diverticulum." Int J Surg Case Rep. 86: 106323.
Backer CL, Russell HM, Wurlitzer KC, Rastatter JC, Rigsby CK. 2012. "Primary resection of Kommerell diverticulum and left subclavian artery transfer." Ann Thorac Surg. 94(5): 1612-1617.
Dumfarth J, Chou AS, Ziganshin BA, Bhandari R, Peters S, Tranquilli M, Mojibian H, Fang H, Rizzo JA, Elefteriades JA. 2015. "Atypical aortic arch branching variants: A novel marker for thoracic aortic disease." J Thorac Cardiovasc Surg. 149(6): 1586-1592.
El Manouni El Hassani S, Niemarkt HJ, Derikx JPM, Berkhout DJC, Ballón AE, de Graaf M, de Boode WP, Cossey V, Hulzebos CV, van Kaam AH, Kramer BW, van Lingen RA, Vijlbrief DC, van Weissenbruch MM, Benninga MA, de Boer NKH, de Meij TGJ. 2021. "Predictive factors for surgical treatment in preterm neonates with necrotizing enterocolitis: a multicenter case-control study." Eur J Pediatr. 180(2): 617-625.
Ellis CL, Bokulich NA, Kalanetra KM, Mirmiran M, Elumalai J, Haapanen L, Schegg T, Rutledge JC, Raff G, Mills DA, Underwood MA. 2013. "Probiotic administration in congenital heart disease: a pilot study." J Perinatol. 33(9): 691-697.
Kim KM, Cambria RP, Isselbacher EM, Baker JN, LaMuraglia GM, Stone JR, MacGillivray TE. 2014. "Contemporary surgical approaches and outcomes in adults with Kommerell diverticulum." Ann Thorac Surg. 98(4): 1347-1354.
McElhinney DB, Hedrick HL, Bush DM, Pereira GR, Stafford PW, Gaynor JW, Spray TL, Wernovsky G. 2000. "Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes." Pediatrics. 106(5): 1080-1087.
Mossad E, Farid I, Youssef G, Ando M. 2002. "Diverticulum of Kommerell: a review of a series and a report of a case with tracheal deviation compromising single lung ventilation." Anesth Analg. 94(6): 1462-1464, table of contents.
Motta C, Scott W, Mahony L, Koch J, Wyckoff M, Reisch J, Burchfield PJ, Brion LP. 2015. "The association of congenital heart disease with necrotizing enterocolitis in preterm infants: a birth cohort study." J Perinatol. 35(11): 949-953.
Natsis K, Piagkou M, Lazaridis N, Kalamatianos T, Chytas D, Manatakis D, Anastasopoulos N, Loukas M. 2021. "A systematic classification of the left-sided aortic arch variants based on cadaveric studies' prevalence." Surg Radiol Anat. 43(3): 327-345.
Stone WM, Ricotta JJ, 2nd, Fowl RJ, Garg N, Bower TC, Money SR. 2011. "Contemporary management of aberrant right subclavian arteries." Ann Vasc Surg. 25(4): 508-514.
Tanaka A, Milner R, Ota T. 2015. "Kommerell's diverticulum in the current era: a comprehensive review." Gen Thorac Cardiovasc Surg. 63(5): 245-259.
Zhou M, Bai X, Ding Y, Wang Y, Lin C, Yan D, Shi Z, Fu W. 2017. "Morphology and Outcomes of Total Endovascular Treatment of Type B Aortic Dissection with Aberrant Right Subclavian Artery." Eur J Vasc Endovasc Surg. 54(6): 722-728.
Published
How to Cite
Issue
Section
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).